当前位置:首页 - 行情中心 - 恒瑞医药(600276) - 财务分析 - 现金流量表

恒瑞医药

(600276)

  

流通市值:3545.45亿  总市值:3688.96亿
流通股本:63.79亿   总股本:66.37亿

现金流量表

报告期2025-12-312025-09-302025-06-302025-03-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金33,605,876,222.7426,173,262,016.0415,666,363,464.516,090,507,617.76
  收到其他与经营活动有关的现金1,228,283,666.84799,560,767.34457,430,575.96211,428,920.53
  经营活动现金流入小计34,834,159,889.5826,972,822,783.3816,123,794,040.476,301,936,538.29
  购买商品、接受劳务支付的现金2,099,963,151.921,167,102,744.63910,938,758.61347,352,720.65
  支付给职工以及为职工支付的现金7,004,960,838.625,462,509,586.423,558,646,926.641,905,586,260.31
  支付的各项税费2,787,135,744.231,839,015,825.491,367,794,099.13652,139,252.4
  支付其他与经营活动有关的现金11,706,722,024.189,393,764,336.575,985,961,004.692,841,684,216.42
  经营活动现金流出小计23,598,781,758.9517,862,392,493.1111,823,340,789.075,746,762,449.78
  经营活动产生的现金流量净额11,235,378,130.639,110,430,290.274,300,453,251.4555,174,088.51
二、投资活动产生的现金流量:
  收回投资收到的现金151,000,000151,000,000150,000,000150,000,000
  取得投资收益收到的现金51,492,129.4430,047,582.8829,112,592.2218,785,809.6
  处置固定资产、无形资产和其他长期资产收回的现金净额18,911,785.277,147,978.593,719,423.421,568,511.61
  投资活动现金流入小计221,403,914.71188,195,561.47182,832,015.64170,354,321.21
  购建固定资产、无形资产和其他长期资产支付的现金2,961,906,284.581,714,462,484.691,267,564,947.42702,031,901.52
  投资活动现金流出小计2,961,906,284.581,714,462,484.691,267,564,947.42702,031,901.52
  投资活动产生的现金流量净额-2,740,502,369.87-1,526,266,923.22-1,084,732,931.78-531,677,580.31
三、筹资活动产生的现金流量:
  吸收投资收到的现金10,351,937,892.2810,351,937,892.2810,351,937,892.28-
  取得借款收到的现金1,495,572,622.12428,335,302.78--
  收到其他与筹资活动有关的现金418,168,545---
  筹资活动现金流入平衡项目000-
  筹资活动现金流入小计12,265,679,059.410,780,273,195.0610,351,937,892.28-
  偿还债务支付的现金1,500,000,000---
  分配股利、利润或偿付利息支付的现金1,284,255,700.451,274,130,192.81,274,130,192.8-
  支付其他与筹资活动有关的现金1,699,715,987.251,415,122,611.081,038,312,699.07661,059,213.92
  筹资活动现金流出小计4,483,971,687.72,689,252,803.882,312,442,891.87661,059,213.92
  筹资活动产生的现金流量净额7,781,707,371.78,091,020,391.188,039,495,000.41-661,059,213.92
四、汇率变动对现金及现金等价物的影响-360,132,552.71-146,577,748.5848,287,663.4729,624,153.66
五、现金及现金等价物净增加额15,916,450,579.7515,528,606,009.6511,303,502,983.5-607,938,552.06
  加:期初现金及现金等价物余额24,239,102,117.6624,239,102,117.6624,239,102,117.6624,239,102,117.66
  期末现金及现金等价物余额40,155,552,697.4139,767,708,127.3135,542,605,101.1623,631,163,565.6
补充资料:
  净利润7,717,002,245.78-4,454,670,657.21-
  资产减值准备86,914,039.97-9,443,508.19-
  固定资产和投资性房地产折旧689,203,837.11-347,244,043.34-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧689,203,837.11-347,244,043.34-
  无形资产摊销114,581,839.37-52,108,856.42-
  长期待摊费用摊销97,702,799.02-43,231,966.88-
  处置固定资产、无形资产和其他长期资产的损失-4,053,134.77--2,311,106.15-
  固定资产报废损失3,289,843.5-1,875,878.05-
  公允价值变动损失-173,573,838.21--111,263,854.42-
  财务费用374,481,650.12--36,624,580.62-
  投资损失57,480,679.6-12,354,120.47-
  递延所得税-403,931,406.24--21,405,272.89-
  其中:递延所得税资产减少-403,782,268.44--32,699,770.72-
    递延所得税负债增加-149,137.8-11,294,497.83-
  存货的减少-479,237,472.88--173,390,260.24-
  经营性应收项目的减少-1,097,175,061.93--691,831,578.87-
  经营性应付项目的增加4,134,810,119.38-280,027,724.23-
  其他53,018,404.41-126,931,999.62-
  现金的期末余额40,155,552,697.41-35,542,605,101.16-
  减:现金的期初余额24,239,102,117.66-24,239,102,117.66-
  现金及现金等价物的净增加额15,916,450,579.75-11,303,502,983.5-
公告日期2026-03-262025-10-282025-08-212025-04-25
审计意见(境内)标准无保留意见
TOP↑